SIGLEC9 and non-small cell lung carcinoma: In NSCLC, SIGLEC9 was coexpressed with CD3 and Sig9+CD8+ TILs exhibited strong PD1 expression and seemed to be a subpopulation of PD1-high CD8 TILs.